Global Antivenom Serum Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3200/- USD | Published Date: April 4, 2021 |

The global antivenom serum market size is expected to grow at significant CAGR of 5.1% and estimated to reach around USD 800 million by 2027. Growing incidence of envenomation in human beings due to the bites of venomous species worldwide primarily drives the antivenom serum market growth. Furthermore, the launch of novel antivenom serums during the forecast period will further bolster the market growth.

Antivenom serum has been recommended for saving lives of millions of people across the globe for more than a century. They are produced by immunizing the donor animals such as horse and sheep with the snake venoms which produces antibodies which neutralizes the toxic effect associated with the envenomation after the bite of any venomous species. There are a few side effects associated with antivenom serums such as wheezing, itching, rapid heartbeats etc., hence recommendation of the accurate antivenom serum is necessary to avoid the above mentioned adverse events.

Market Segment Insights:

Snakes are representing the largest market share in the species segment for antivenom serum market growth. According to the latest research citings presented by the World Health Organization, (WHO), approximately 5.4 million snake bites are reported worldwide. Large scale deforestation and reclamation of marshy lands are the chief reasons for the number of reported incidents of snake bites among cultivators worldwide. Spiders are going to register steady market growth during the forecast period, it is a well-known fact that there are almost 40,000 different species of spiders occurring across the globe, but only a dozen of these are highly venomous and cause life threatening outcomes in human beings subjected to its envenomation.

Antivenom Serum Market Size and Growth

To know more about the study, request a report sample

Hospital pharmacy is currently spearheading the distribution channel segment for antivenom serum market. People bitten with venomous species are first taken to the primary healthcare center where they are immediately given an antivenom serum to save the life of the patient, however precise dispensing of antivenom serum in accordance to doctor’s prescription is mandatory to prevent the outcome of side effects. Retail pharmacy is expected to showcase comfortable market growth in the developing regions owing to the availability of antivenom serums at affordable prices and ability to cater the medicinal requirements of patients residing in the remote locations.

The antivenom serum  market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

  • 2018-19 – Historical Year
  • 2020 – Base Year
  • 2021-2027 – Forecast Period

Global Antivenom Serum Market Segmentation:

By Species:

  • Snakes
  • Scorpions
  • Spiders
  • Others

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Geographic Coverage:

Asia Pacific is presently dominating the geography segment for antivenom serum market. Constant rise in the number of people reported to be suffering with the bites of venomous snakes primarily drives the market growth. The tropical climates of South East Asia is the house of the most venomous snakes found on the planet and the dry lands of the South Asian countries provided favorable breeding grounds for poisonous scorpions. Existence of key players such as Serum Biotec Limited, Vins Bioproducts Limited, Incepta Vaccines Ltd. etc further accentuate the market growth in the region. Latin America is the second largest regional segment owing to the presence of amazon rain forest which has presence of several varieties of venomous spiders. North America is anticipated to be the fastest growing regional segment in the antivenom serum market. Existence of developed healthcare infrastructure and rising public health awareness together determine the antivenom serum market growth in the region.

Market Competition Assessment:

Key players operating in the global antivenom serum  market are Merck KGaA, Haffkine Bio Pharmaceutical Corporation Ltd., Serum Biotec Limited, Pfizer, Inc., and Incepta Vaccines Ltd.. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

List of Key Companies:

  • Merck KGaA
  • Summerland Serums
  • Haffkine Bio Pharmaceutical Corporation Ltd.
  • MicroPharm
  • Serum Biotec Limited
  • SAVP
  • Vins Bioproducts Limited.
  • Incepta Vaccines Ltd.
  • Pfizer, Inc.
  • Rare Disease Therapeutics, Inc.

Key Questions Answered by Antivenom serum Market Report:

  • Global antivenom serum  market forecasts from 2021-2027
  • Regional antivenom serum  market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
  • Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
  • Antivenom serum  submarket forecasts from 2021-2027 covering the market by species, by distribution channel, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis pertaining to antivenom serum  market
  • Analysis of the key factors driving and restraining the growth of the global, regional and country-level antivenom serum  markets from 2021-2027
  • Competitive Landscape and market positioning of top 10 players operating in the antivenom serum  market
Table of Content:

Chapter 1. Introduction


1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Scope
1.3.1. Market Segmentation
1.3.2. Years Considered for the Study
1.4. Currency
1.5. Limitation
1.6. Market Stakeholders

 

Chapter 2. Research Methodology


2.1. Market Size Estimation
2.2. Market Breakdown and Data Triangulation
2.3. Market Share Estimation
2.4. Key Data From Secondary Sources
2.5. Key Data From Primary Sources
2.6. Key Industry Insights
2.7. Assumptions for the Study

 

Chapter 3. Executive Summary


3.1. Global Antivenom Serum Market Snapshot
3.2. Global Antivenom Serum Market, by Species, 2020 (US$ Mn)
3.3. Global Antivenom Serum Market, By Distribution Channel, 2020 (US$ Mn)
3.4. Global Antivenom Serum Market, by Geography, 2020 (US$ Mn)

 

Chapter 4. Antivenom Serum Market: Dynamics and Future Outlook


4.1. Market Overview
4.2. Drivers
4.3. Challenges
4.4. Opportunities
4.5. Attractive Investment Proposition, by Geography, 2020

 

Chapter 5. Global Antivenom Serum Market, by Species


5.1. Introduction
5.2. Snakes
5.3. Scorpions
5.4. Spiders
5.5. Others

 

Chapter 6. Global Antivenom Serum Market, By Distribution Channel


6.1. Introduction
6.2. Hospital Pharmacy
6.3. Retail Pharmacy
6.4. Others

 

Chapter 7. Global Antivenom Serum Market, by Geography


7.1. Introduction
7.1. North America Antivenom Serum Market Analysis, 2017 – 2027
7.1.1. North America Antivenom Serum Market, by Species, 2017 – 2027 (US$ Mn)
7.1.2. North America Antivenom Serum Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.1.3. North America Antivenom Serum Market, by Country, 2017 – 2027 (US$ Mn)
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe Antivenom Serum Market Analysis, 2017 – 2027
7.2.1. Europe Antivenom Serum Market, by Species, 2017 – 2027 (US$ Mn)
7.2.2. Europe Antivenom Serum Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.2.3. Europe Antivenom Serum Market, by Country, 2017 – 2027 (US$ Mn)
7.2.3.1. U.K.
7.2.3.2. Germany
7.2.3.3. Russia
7.2.3.4. France
7.2.3.5. Italy
7.2.3.6. Spain
7.2.3.7. Ukraine
7.2.3.8. Rest of Europe
7.3. Asia Pacific Antivenom Serum Market Analysis, 2017 – 2027
7.3.1. Asia Pacific Antivenom Serum Market, by Species, 2017 – 2027 (US$ Mn)
7.3.2. Asia Pacific Antivenom Serum Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.3.3. Asia Pacific Antivenom Serum Market, by Country, 2017 – 2027 (US$ Mn)
7.3.3.1. China
7.3.3.2. Japan
7.3.3.3. Rest of Asia Pacific
7.4. Latin America Antivenom Serum Market Analysis, 2017 – 2027
7.4.1. Latin America Antivenom Serum Market, by Species, 2017 – 2027 (US$ Mn)
7.4.2. Latin America Antivenom Serum Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.4.3. Latin America Antivenom Serum Market, by Country, 2017 – 2027 (US$ Mn)
7.4.3.1. Brazil
7.4.3.2. Mexico
7.4.3.3. Rest of Latin America
7.5. Middle East and Africa Antivenom Serum Market Analysis, 2017 – 2027
7.5.1. MEA Antivenom Serum Market, by Species, 2017 – 2027 (US$ Mn)
7.5.2. MEA Antivenom Serum Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.5.3. MEA Antivenom Serum Market, by Country/Region, 2017 – 2027 (US$ Mn)
7.5.3.1. GCC
7.5.3.2. Rest of MEA

 

Chapter 8. Company Profiles


8.1. Merck KGaA
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Recent Developments
8.1.5. SWOT Analysis
8.2. Summerland Serums
8.3. Haffkine Bio Pharmaceutical Corporation Ltd.
8.4. MicroPharm
8.5. Serum Biotec Limited
8.6. SAVP
8.7. Vins Bioproducts Limited.
8.8. Incepta Vaccines Ltd.
8.9. Pfizer, Inc.
8.10. Rare Disease Therapeutics, Inc.

To know more about the study, request a report sample

List of Figures

FIG. 1 Antivenom Serum: Market Segmentation
FIG. 2 Global Antivenom Serum Market, by Species, 2019 (US$ Mn)
FIG. 3 Global Antivenom Serum Market, By Distribution Channel, 2019 (US$ Mn)
FIG. 4 Global Antivenom Serum Market, by Geography, 2019 (US$ Mn)
FIG. 5 Attractive Investment Proposition: by Geography, 2019
FIG. 6 Global Snakes Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 7 Global Scorpion Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 8 Global Spiders Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 9 Global Other Species Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 10 Global Hospital Pharmacy Market for Antivenom Serum, 2017 – 2027 (US$ Mn)
FIG. 11 Global Retail Pharmacy Market for Antivenom Serum, 2017 – 2027 (US$ Mn)
FIG. 12 Global Other Distribution Channel Market for Antivenom Serum, 2017 – 2027 (US$ Mn)
FIG. 13 U.S. Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 14 Canada Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 15 U.K. Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 16 Germany Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 17 Russia Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 18 France Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 19 Italy Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 20 Spain Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 21 Ukraine Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 22 Rest of Europe Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 23 China Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 24 Japan Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 25 Rest of Asia Pacific Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 26 Brazil Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 27 Mexico Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 28 Rest of Latin America Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 29 GCC Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 30 Rest of MEA Antivenom Serum Market, 2017 – 2027 (US$ Mn)
FIG. 31 Antivenom Serum Market: Research Methodology

To know more about the study, request a report sample

List of Tables

TABLE 1 Global Antivenom Serum Market Snapshot
TABLE 2 Global Antivenom Serum Market, by Species, 2017 – 2027 (US$ Mn)
TABLE 3 Global Antivenom Serum Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 4 Global Antivenom Serum Market, by Geography, 2017 – 2027 (US$ Mn)
TABLE 5 North America Antivenom Serum Market, by Species, 2017 – 2027 (US$ Mn)
TABLE 6 North America Antivenom Serum Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 7 North America Antivenom Serum Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 8 Europe Antivenom Serum Market, by Species, 2017 – 2027 (US$ Mn)
TABLE 9 Europe Antivenom Serum Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 10 Europe Antivenom Serum Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 11 Asia Pacific Antivenom Serum Market, by Species, 2017 – 2027 (US$ Mn)
TABLE 12 Asia Pacific Antivenom Serum Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 13 Asia Pacific Antivenom Serum Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 14 Latin America Antivenom Serum Market, by Species, 2017 – 2027 (US$ Mn)
TABLE 15 Latin America Antivenom Serum Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 16 Latin America Antivenom Serum Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 17 Middle East and Africa Antivenom Serum Market, by Species, 2017 – 2027 (US$ Mn)
TABLE 18 Middle East and Africa Antivenom Serum Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 19 Middle East and Africa Antivenom Serum Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 20 Merck KGaA.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 21 Summerland Serums: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 22 Haffkine Bio Pharmaceutical Corporation Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 23 MicroPharm: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 24 Serum Biotec Limited: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 25 SAVP: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 26 Vins Bioproducts Limited.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 27 Incepta Vaccines Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 28 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 29 Rare Disease Therapeutics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
Fill the given form to inquiry before buying for Antivenom Serum Market Report

Your Designtaion (required):


(Reports covers the COVID-19 impacts on the market)

Request Report Sample
Inquiry Before Buying
Select License Type
$3200/- Single User License
$4800/- Multi User License
$6400/- Corporate License

Paypal Certified Payment
Why To Choose Us:
  • Markets in over 150 countries analyzed granularly
  • 35% of our total client are returning clients
  • 100,000+ data points in our comprehensive database
  • 24x5 availability - we are always there when you need us
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report
  • We focus on the accuracy and quality of the report
  • Our analyst will provide deep insights into the report

Impacts of COVID-19
COVID-19 Impact on the Antivenom Serum Market

For Any Assitance

Call Us: +1 520-686-7060
Email: sales@researchcorridor.com

Our Clients